ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "inflammation and psoriatic arthritis"

  • Abstract Number: 1618 • 2018 ACR/ARHP Annual Meeting

    Adipose Tissue Inflammation in Psoriatic Arthritis: Overexpression of a Wide Array of Inflammatory Mediators and Associations with Disease and Treatment Characteristics

    Jae Hee Yun1, Robert Winchester2, Hui-Zhu Zhang2, Christopher Depender1 and Jon T. Giles1, 1Medicine/Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 2Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY

    Background/Purpose: Obesity is associated with PsA risk, severity, and lack of response to DMARDs.  However, no studies have explored adipose tissue inflammation at the molecular…
  • Abstract Number: 1682 • 2016 ACR/ARHP Annual Meeting

    Tnfα Inhibitors Are Associated with Reduced Progression of Carotid Atherosclerotic Plaques By Ultrasound and an Improvement in Aortic Arch Vascular Inflammation By 18-FDG PET/CT in Psoriasis and Psoriatic Arthritis Patients – a Prospective Study from Two Cohorts

    Lihi Eder1, Aditya Joshi2, Vinod Chandran3, Amit Dey4, Richard J. Cook5, Abhishek Chaturvedi6, Dafna D. Gladman7 and Nehal Mehta8, 1Medicine, University of Toronto, Women's College Hospital, Toronto, ON, Canada, 2National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 3Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 4National Institutes of Health, Bethesda, MD, 5Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada, 6National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, 7Rheumatology, Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 8National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD

    Background/Purpose:  Psoriasis (PSO) and psoriatic arthritis (PsA) are chronic inflammatory diseases which are associated with increased cardiovascular (CV) diseases. Observational studies have found that TNFα…
  • Abstract Number: 1582 • 2014 ACR/ARHP Annual Meeting

    Cumulative Inflammatory Burden Is Independently Associated with Increased Arterial Stiffness in Patients with Psoriatic Arthritis

    Jiayun Shen1, Qing Shang1, Ying Ying Leung2, Edmund Li1, Tracy Y. Zhu1 and Lai-Shan Tam1, 1Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong, 2Department of Rheumatology and Immunology, Singapore General Hospital, Singapore, Singapore

    Background/Purpose: Patients with psoriatic arthritis (PsA) are at increased risk of cardiovascular (CV) morbidity compared with the general population, probably as a result of chronic…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology